Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin Ocular Implant in Cataract Surgery
NCT05441930Phase 1Withdrawn
- Sponsor
- PolyActiva
- Start
- Jun 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, randomised, open-label trial of levofloxacin in endophthalmitis (2 arms), sponsored by PolyActiva. Primary endpoints: Safety of the Levofloxacin Ocular Implant at Day 90 and Levofloxacin concentration in aqueous humor at Day 5. Planned start Jun 2023; status: withdrawn.
02
Drugs
levofloxacin
03
Conditions
endophthalmitis
Beyond the preview
Go deeper on NCT05441930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05441930.